End-stage hemolytic rate of leukocyte-reduced RBCs in additive solution: a 5-year retrospective study

Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 11

Abstract

Objective To evaluate the suitability of current quality standard for end-stage hemolytic rate required by Quality Requirements for Whole Blood and Blood Components in Taiyuan through a 5- year retrospective analysis of leukocyte-reduced RBCs in additive solution in Taiyuan Blood Center. Methods A total of 240 packs of leukocyte-reduced RBCs in additive solution were collected from January 2007 to December 2021. Hb concentration, hematocrit(Hct) and free Hb in supernatant at end-stage were detected to measure the hemolytic rate. And the hemolytic rate was then compared with the current standard(0.8%) to analyze whether statistical differences existed. Results The hemolytic rate of leukocyte-reduced RBCs in additive solution were 0.109±0.123 in 2017, 0.113±0.085 in 2018, 0.121±0.076 in 2019, 0.101±0.057 in 2020, and 0.128±0.089 in 2021, with no significant difference among each other (P>0.05). And 97.5% of the products showed an end-stage hemolytic rate below 0.4%, 0.83% among 0.6%~0.7%, and none over the standard of 0.8%. Conclusion The current national standard for end-stage hemolytic rate of leukocyte-reduced RBCs in additive solution might not be suitable for blood quality control in Taiyuan, and a much stricter criteria should be considered.

Authors and Affiliations

Yanhong WAN, Yanyu LI, Wen LIU, Shijing PEI

Keywords

Related Articles

Application of quality monitoring indicators of blood testing in blood banks of Shandong province

Objective To objectively evaluate the quality control level of blood testing process in blood banks through quantitative monitoring and trend analysis, and to promote the homogenization level and standardized management...

Changes of cryoprecipitate coagulation factors prepared by different preparation methods and quick-freezing time

Objective To analyze the changes of fibrinogen (Fg) and Ⅷ factor levels of cryoprecipitated coagulation factors prepared by different methods and post-preparation quick-freezing time. Methods The fresh frozen plasma (FFP...

Prevalence of blood donation related vasovagal reactions in China: a systematic review and Meta-analysis

Objective To systematically evaluate the incidence of donation related vasovagal reactions (DRVR) in China by Meta-analysis method and discuss the risk factors of DRVR, so as to provide scientific basis for the preventio...

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to...

Autologous platelet-rich plasma treatment for infected deep second-degree burn wounds: a case report

Objective To explore the feasibility of using autologous platelet-rich plasma (PRP) in the treatment of deep second-degree burns complicated with wound infection. Methods A retrospective analysis was conducted on the tre...

Download PDF file
  • EP ID EP738411
  • DOI 10.13303/j.cjbt.issn.1004-549x.2022.11.016
  • Views 5
  • Downloads 0

How To Cite

Yanhong WAN, Yanyu LI, Wen LIU, Shijing PEI (2022). End-stage hemolytic rate of leukocyte-reduced RBCs in additive solution: a 5-year retrospective study. Chinese Journal of Blood Transfusion, 35(11), -. https://europub.co.uk/articles/-A-738411